Cellulitis - I-Cellulitis
☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Umlenze yindawo eqhelekileyo ye Cellulitis (Cellulitis).
Imeko eqhelekileyo.
Inqanaba lokuphilisa
relevance score : -100.0%
ReferencesI-Cellulitis lusulelo oluqhelekileyo lolusu lwebhaktiriya. Ichaphazela abantu abangaphezu kwezigidi ezili-14 ngonyaka e-United States. Ikhokelela malunga ne-$3.7 yezigidigidi kwiindleko zokunakekelwa kwe-ambulatory kunye ne-650,000 esibhedlele ngonyaka. Ngokuqhelekileyo, i-Cellulitis ibonakala njengendawo efudumeleyo, ebomvu esikhumbeni, enodumba nokuthantamisa. Ibangelwa lusulelo lwebhaktiriya ngesiquphe esibangela ukudumba kolusu olunzulu kunye nezicubu ezikufutshane. Akukho thumba okanye ubovu ngolu suselelo. I-Beta-hemolytic streptococci, ingakumbi iqela A streptococcus (Streptococcus pyogenes), zizinto eziqhelekileyo, ezilandelwa yi-methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis lusulelo lwebhaktiriya yolusu kunye nezicubu ezithambileyo. Kwenzeka xa kukho imiba kunye nomqobo wokukhusela ulusu, amajoni omzimba, okanye ukujikeleza kwegazi. Isifo sikashukela, ukutyeba, kunye nobudala kwandisa amathuba e‑cellulitis ngokuchaphazela ezi ndawo. Sijonga iziphumo zakutshanje ekuxilongeni i‑cellulitis, kuqaqambisa ukubaluleka koxilongo oluchanekileyo kuba iimeko ezifana nokungoneli kwe‑venous, i‑eczema, i‑deep vein thrombosis, kunye ne‑gout zihlala zibhidaniswa ne‑cellulitis. Amayeza okubulala iintsholongwane asetyenziselwa ukunyanga i‑cellulitis akhethwa ngononophelo ukujolisa ibhaktheriya eqhelekileyo ngaphandle kokukhuthaza ukuxhathisa amayeza. Sithetha malunga ne‑antibiotics entsha evunyiweyo ye‑cellulitis. I‑cellulitis ihlala ibuya ngenxa yezinto eziqhubekayo zomngcipheko kunye nomonakalo kwinkqubo ye‑lymphatic.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Abantu abaninzi baya ezibhedlele okanye kumagumbi okuxakeka ngenxa yosulelo lolusu lwebhaktiriya ngequbuliso. Staphylococcus aureus yeyona ntsholongwane ephambili ebangela olu sulelo, kwaye kuya kuba nzima ukunyanga kuba ezinye iintlobo ziyaxhathisa kwi‑antibiotics eziqhelekileyo.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Staphylococcus aureus inokwahlulwa ibe ziindidi ezimbini ngokusekelwe kwimpendulo yazo kwi‑antibiotics: methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA). Kule minyaka edlulileyo, ngenxa yokuvela kwebhaktiriya kunye nokusetyenziswa ngokugqithisileyo kwamayeza okubulala iintsholongwane, ukuxhathisa kwe‑S. aureus kumachiza kuye kwenyuka, okukhokelela ekunyukeni kwamazinga e‑MRSA kwihlabathi jikelele.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
Imilenze kunye nobuso ziindawo ezixhaphakileyo ezibandakanyekayo. Izinto ezibangelayo zibandakanya ukutyeba, ukudumba kwemilenze, kunye nokwaluphala. Iibhaktheriya ezivame ukubandakanyeka yi‑streptococci kunye ne‑Staphylococcus aureus.
Unyango luhlala lusetyenziswa ngamayeza okubulala iintsholongwane athathwa ngomlomo, afana ne‑cephalexin, i‑amoxicillin, okanye i‑cloxacillin. Malunga nama‑95 % abantu batyelela ukuphola emva kweentsuku ezisi‑7 ukuya kwezili‑10 zonyango. Noko ke, abantu abanesifo seswekile bavame ukuba neziphumo ezimbi.
I‑Cellulitis sisifo esixhaphakileyo, kwaye e‑United Kingdom, i‑cellulitis ibanga i‑1.6 % yokungeniswa esibhedlele. Ngo‑2015, i‑Cellulitis ibangele ukufa kwabantu aba‑16 900 kwihlabathi jikelele.
○ Unyango ― OTC Amachiza
I‑cellulitis enzima ifuna unyango kunye ne‑antibiotics ezichazwe ngugqirha kuphela. Ukuba isilonda sikhula ngokukhawuleza kwaye sihambisana nomkhuhlane kunye ne‑chills, kuyacetyiswa ukuba ubone ugqirha ngokukhawuleza.
Ukufaka i‑ointment ye‑antibiotic kwi‑over‑the‑counter kwizilonda zakwangoku kunokunceda. Ukuba i‑ointment isetyenziswe kakhulu, ingasebenzi.
#Polysporin
#Bacitracin
#Betadine
Sebenzisa izithomalalisi zeentlungu ze‑OTC ezifana ne‑acetaminophen ukuthomalalisa iintlungu.
#Ibuprofen
#Naproxen
#Acetaminophen
Gcina iinyawo zicocekile kwaye uphathe unyawo lomdlali, kuba unyawo lomdlali lunokunyusa umngcipheko we‑cellulitis.
○ Unyango
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)